Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma

Title
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma
Authors
Keywords
Ewing sarcoma, Relapse, Paediatric, Phase II trial, Cisplatin, VP-16
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 71, Issue 2, Pages 399-404
Publisher
Springer Nature
Online
2012-11-17
DOI
10.1007/s00280-012-2015-7

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now